Increased natural killer cell activity in patients with epidermodysplasia verruciformis.

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Abstract Text:

Six patients with epidermodysplasia verruciformis (EV) were studied for natural killer cell (NKC) cytotoxic response of their peripheral blood mononuclear cells against K-562 target cells in an 18-hour chromium 51-release assay. Four patients displayed higher cytotoxic responses than controls did, whereas two others did not differ from controls. Patients with EV who had increased NKC activity were found to be infected with potentially oncogenic human papillomaviruses (types 5, 8, 9, 14, 17, 19, 22, 24, and others), and they have had multiple skin carcinomas and/or Bowen's precancerous dermatosis. Two patients with EV who had normal cytotoxic response were free of skin malignancies.

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Publishing Authors By Initials

For similar virus diseases: tumor virus infections research abstracts see: virus diseases: tumor virus infections research

PUBMED ID PMID:

MEDLINE DATE:

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Archives of dermatology

VOLUME: 121

Page Numbers: 84-6

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Jan

YEAR: 1985

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Keywords Mesh Terms:

KEYWORDS: Tumor Virus Infections

MESH TERMS: pathology

Chemical & Substance for Abstract: Increased natural killer cell activity in patients with epidermodysplasia verruciformis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Increased natural killer cell activity in patients with epidermodysplasia verruciformis.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Increased natural killer cell activity in patients with epidermodysplasia verruciformis Related Publications

• A comparison of the effectiveness of dihydroergotamine (DHE-45) and dihydroergocornine (DHO-180) in the prevention of cardiac irregularities during cyclopropane anesthesia.
• A newly discovered post-translational modification--the acetylation of serine and threonine residues.
• An unusual wart-like skin lesion found in a renal allograft recipient.
• Arp2/3-independent assembly of actin by Vibrio type III effector VopL.
• Branch retinal venous occlusion.
• Centralised versus decentralised wastewater systems?
• Chronic toxicity of thiomerin compared to other mercurial diuretics.
• Cytokines may favor a role for human papillomaviruses in the pathogenesis of psoriasis.
• Ectopic production of ACTH, lipotropin, and beta-endorphin by human cancer cells. Structurally related tumor markers.
• Food' requirements in the arctic regions.
• Human papillomavirus: cause of epithelial lacrimal sac neoplasia?
• Increased natural killer cell activity in patients with epidermodysplasia verruciformis.
• Liabilities in the use of morphine.
• Non-invasive ventilation in chronic obstructive pulmonary disease.
• Sodium zeolite a supplementation and its impact on the skeleton of dairy calves.
• Structural Requirements for Yersinia YopJ Inhibition of MAP Kinase Pathways.
• Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases.
• The elusive activity of the Yersinia protein kinase A kinase domain is revealed.
• The use of dihydroergotamine (D.H.E. 45) and dihydroergocornine (D.H.O. 180) to prevent cardiac irregularities during cyclopropane anesthesia.
• Tissue response to a supplement high in aluminum and silicon.
• Vestibular papillae of the vulva. Lack of evidence for human papillomavirus etiology.
• VopA Inhibits ATP Binding by Acetylating the Catalytic Loop of MAPK Kinases.
• Yersinia outer proteins: Yops.
• [Adverse renal effects of legal and illicit drugs]
• [Cholecystectomy--the gold standard of therapy]
• [Complication of blood transfusion due to Rh incompatibility, with atypical anamnesis.]
• [Detection and mapping of conserved nucleotidic sequences between the genomes of human papillomavirus 1 a and bovine papillomavirus 1 by electron microscope heteroduplex analysis (author's transl)]
• [Idiopathic edema]
• [Not Available.]
• cAMP-induced expression of ABCA1 is associated with MAP-kinase-pathway activation.